Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals ALNY
$ 250.14 0.06%

Annual report 2024
added 02-13-2025

report update icon

Alnylam Pharmaceuticals Financial Ratios 2011-2025 | ALNY

Annual Financial Ratios Alnylam Pharmaceuticals

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-122.0 -42.3 -21.0 -21.9 -19.8 -14.2 -10.8 -24.2 -7.7 -20.0 -19.3 -59.3 -11.3 -8.2

P/S

15.1 10.2 22.9 22.1 34.6 57.4 109.7 132.2 66.9 140.9 137.8 112.1 17.9 5.7

EPS

-2.2 -3.5 -9.3 -7.2 -7.5 -8.1 -7.6 -5.4 -4.8 -3.5 -4.8 -1.4 -2.1 -1.4

EV (Enterprise Value)

37.1 B 21.9 B 26.6 B 20.9 B 18.9 B 13 B 8.07 B 11.5 B 3.31 B 5.73 B 7.04 B 5.38 B 1.3 B 567 M

EBITDA per Share

-0.94 -1.83 -6.09 -5.58 -6.9 -8.1 -8.03 -5.37 -4.78 -3.3 -2.32 -1.34 -1.08 -1.17

EV/EBITDA

-31.5 -22.5 -13.6 -9.7 -23.2 -7.6 -20.3 -40.0 -63.3 -21.0 -8.1

PEG

4.25 2.25 -4.12 -3.82 -1.07 2.0 0.27 1.84 0.2 -0.69 0.08 -1.89 0.2 0.27

P/B

505.7 -84.5 -150.0 31.8 16.8 8.8 6.3 6.7 3.4 4.6 7.4 19.6 8.9 4.0

P/CF

-4082.0 178.9 -43.8 -29.1 -27.7 -30.1 -11.9 -24.4 -8.5 -28.7 -39.9 -72.8 -9.7 -5.4

ROE %

-414.62 199.53 714.91 -144.99 -84.46 -61.59 -58.49 -27.79 -44.57 -22.94 -38.49 -33.00 -79.08 -48.86

ROA %

-6.56 -11.49 -31.90 -23.41 -25.19 -37.00 -48.36 -24.61 -32.48 -20.92 -33.38 -21.22 -36.87 -20.45

ROCE %

-263.66 127.89 496.18 -120.48 -81.52 -45.99 -58.39 -27.02 -37.54 -22.35 -18.72 -25.35 -26.58 -27.28

Current Ratio

1.0 0.9 1.0 1.2 1.4 4.9 6.7 12.2 5.1 17.8 7.8 4.7 2.6 1.9

DSO

16.4 13.2 18.6 23.1 17.9 71.4 91.4 138.0 180.6 73.7 288.3 32.9 0.6 6.5

DIO

99.8 148.4 280.3 256.4 323.6 820.6 4875.0 - - - - - - -

DPO

85.7 104.5 223.3 199.0 250.6 726.5 12094.0 - - - - - - -

Operating Cycle

116.2 161.6 298.9 279.5 341.6 892.1 4966.4 - - - - - - -

Cash Conversion Cycle

30.6 57.0 75.6 80.5 91.0 165.6 -7127.6 - - - - - - -
P/E
P/S
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
202420242023202320222022202120212020202020192019201820182017201720162016201520152014201420132013201220122011201116000 16000 12000 12000 8000 8000 4000 4000 0 0 -4000 -4000 -8000 -8000
Download SVG
Download PNG
Download CSV

All numbers in USD currency

Quarterly Financial Ratios Alnylam Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.87 -0.13 -0.52 - 1.18 -2.21 -1.4 - -3.32 -2.29 -2 - -1.72 -1.61 -1.71 -2.09 -2.18 -1.56 -1.62 -2.47 -1.92 -2.02 -1.73 -2.09 -2.43 -1.63 -1.41 -1.48 -1.34 -1.34 -1.25 -1.32 -1.21 -1.05 -1.21 -1.07 -0.91 -0.85 -0.62 -0.28 -0.58 -0.58 -3.7 -0.51 -0.48 -0.29 -0.15 -1.2 -0.38 -0.25 -0.25 -0.33 -0.31 -0.33 -0.38

EBITDA per Share

- - -0.24 - - - -1.09 - -1.87 -1.59 -1.14 - -1.22 -1.24 -1.48 - -1.73 -1.59 -1.8 - -1.88 -2.11 -1.75 - -2.47 -1.86 -1.44 - -1.26 -1.3 -1.2 - -1.1 -0.98 -1.24 - -0.76 -0.76 -0.59 - -0.48 -0.52 -3.93 - -0.39 -0.27 -0.13 - -0.22 -0.14 -0.19 - -0.2 -0.25 -0.34

ROE %

146.82 402.58 -80.46 45.71 645.85 1335.06 1109.85 382.65 355.59 -271.60 -136.24 -70.89 -94.86 -92.73 -88.15 -84.46 -79.69 -69.26 -66.88 -61.59 -58.63 -62.98 -60.29 -58.49 -50.30 -38.42 -32.56 -27.79 -32.01 -36.36 -39.45 -44.57 -39.47 -34.23 -30.11 -22.94 -18.05 -16.67 -15.71 -38.49 -48.18 -54.46 -56.47 -33.00 -67.43 -70.99 -73.94 -79.08 -44.81 -41.48 -43.54 -48.86 -11.22 -11.72 -13.80

ROA %

-0.95 5.55 -2.14 -9.40 -20.88 -36.21 -35.10 -25.48 -31.37 -18.78 -24.18 -17.44 -24.59 -26.14 -26.00 -25.19 -29.57 -30.85 -34.75 -37.00 -38.89 -45.76 -46.98 -48.36 -42.06 -32.65 -28.20 -24.61 -26.42 -28.50 -29.70 -32.48 -30.08 -27.37 -25.41 -20.92 -16.36 -14.90 -13.80 -33.38 -39.10 -42.08 -42.32 -21.22 -35.15 -34.88 -35.06 -36.87 -20.32 -18.23 -18.63 -20.45 -4.70 -4.90 -5.78

ROCE %

-1931.90 -1823.14 -181.76 -14.84 366.66 877.10 711.90 236.04 212.00 -193.53 -101.77 -61.27 -83.43 -81.56 -84.00 -62.41 -77.44 -70.32 -67.17 -44.58 -64.13 -68.65 -67.00 -45.65 -52.77 -40.34 -32.39 -19.97 -31.56 -36.03 -39.26 -33.60 -39.79 -34.39 -30.11 -16.09 -20.92 -19.55 -18.59 -38.37 -50.30 -57.39 -60.47 -23.43 -36.97 -38.58 -39.70 -30.66 -41.21 -38.21 -40.33 -34.94 -10.54 -11.12 -13.29

Current Ratio

1.0 1.0 0.9 0.9 1.0 0.9 0.9 1.0 1.0 - 1.1 1.2 1.3 1.3 1.4 1.4 1.4 1.4 1.4 2.5 2.5 2.5 2.5 5.8 5.8 5.8 5.8 8.7 8.7 8.7 8.7 3.7 3.7 3.7 3.7 11.4 11.4 11.4 11.4 7.5 7.5 7.5 7.5 2.8 2.8 2.8 2.8 1.9 1.9 1.9 1.9 1.7 1.7 1.7 1.7

DSO

60.4 43.6 59.9 - 33.2 63.0 65.4 - 3.8 4.8 20.7 - 14.0 11.0 13.5 18.7 24.3 29.4 22.2 19.0 19.4 30.5 28.2 24.4 248.1 17.2 82.6 58.5 80.2 141.5 138.0 - - - - - - - - - - - - - - - - - -5.9 -8.3 -80.7 - -286.8 -132.4 -

DIO

89.0 120.7 153.0 - 112.7 140.7 287.2 - 144.3 105.2 320.7 - 296.0 238.7 295.6 - 329.5 375.7 451.2 - 986.3 1188.6 1096.2 - 16030.7 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

80.6 103.2 111.7 - 76.7 73.9 176.6 - 50.7 73.6 249.6 - 151.3 148.5 192.9 - 227.7 259.6 349.3 - 873.2 1052.2 1493.9 - 39769.0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

149.4 164.3 212.9 - 145.8 203.7 352.6 - 148.1 110.0 341.4 - 310.0 249.7 309.1 18.7 353.8 405.1 473.4 19.0 1005.8 1219.0 1124.4 24.4 16278.8 17.2 82.6 58.5 80.2 141.5 138.0 - - - - - - - - - - - - - - - - - -5.9 -8.3 -80.7 - -286.8 -132.4 -

Cash Conversion Cycle

68.9 61.1 101.2 - 69.2 129.8 176.0 - 97.4 36.4 91.8 - 158.8 101.2 116.2 18.7 126.1 145.5 124.1 19.0 132.6 166.8 -369.6 24.4 -23490.2 17.2 82.6 58.5 80.2 141.5 138.0 - - - - - - - - - - - - - - - - - -5.9 -8.3 -80.7 - -286.8 -132.4 -
P/E
P/S
EPS
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
202420242023202320222022202120212020202020192019201820182017201720162016201520152014201420132013201220122011201116000 16000 12000 12000 8000 8000 4000 4000 0 0 -4000 -4000 -8000 -8000
Download SVG
Download PNG
Download CSV

All numbers in USD currency